Cargando…

Early administration of ivabradine in patients admitted for acute decompensated heart failure

BACKGROUND: Heart rate (HR) control is important in heart failure (HF) patients with reduced ejection fraction, and ivabradine is indicated for patients with chronic HF and sinus rhythm. However, ivabradine is limited in initiation of ivabradine at acute stage of HF. MATERIALS AND METHODS: This mult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Teng-Yao, Tsai, Meng-shu, Jan, Jeng-Yu, Chang, Jung-Jung, Chung, Chang-Ming, Lin, Ming-Shyan, Chen, Hui-Ming, Lin, Yu-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744812/ https://www.ncbi.nlm.nih.gov/pubmed/36523364 http://dx.doi.org/10.3389/fcvm.2022.1036418

Ejemplares similares

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
por: Lin, Yu‐Sheng, et al.
Publicado: (2022)

In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization
por: Faragli, Alessandro, et al.
Publicado: (2021)

Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
por: Nakano, Yusuke, et al.
Publicado: (2021)

Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction
por: Tsai, Ming-Lung, et al.
Publicado: (2023)

The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients
por: Liao, Chia‐Te, et al.
Publicado: (2021)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
por: Yang, Juntao, et al.
Publicado: (2023)

A case report of ivabradine used for heart rate control of atrial fibrillation in acute decompensated heart failure
por: Hardison, Edward, et al.
Publicado: (2022)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
por: Lee, Ying‐Hsiang, et al.
Publicado: (2021)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Implementation of a heart failure educational intervention for patients with recent admissions for acute decompensated heart failure
por: Stahlman, Sarah, et al.
Publicado: (2023)

Identification of decompensation episodes in chronic heart failure patients based solely on heart sounds
por: Susič, David, et al.
Publicado: (2022)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
por: Inoue, Tomoko, et al.
Publicado: (2023)

Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure
por: Diaz-Riera, Elisa, et al.
Publicado: (2022)

Feasibility and safety of 1-min sit-to-stand test in acute decompensated heart failure confirmed by lung ultrasound
por: Zhang, Xiu, et al.
Publicado: (2023)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF)
por: Ezekowitz, Justin A, et al.
Publicado: (2016)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials
por: Gong, Bojun, et al.
Publicado: (2016)

Case Report: Ambient Sensor Signals as Digital Biomarkers for Early Signs of Heart Failure Decompensation
por: Saner, Hugo, et al.
Publicado: (2021)

Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure: a meta-analysis
por: Chen, Shuai, et al.
Publicado: (2023)

Efficacy of ivabradine for heart failure: A protocol for a systematic review of randomized controlled trial
por: Xue, En-zhong, et al.
Publicado: (2019)

Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
por: Lin, Ming-Shyan, et al.
Publicado: (2023)

Elevated Plasma Big Endothelin-1 at Admission Is Associated With Poor Short-Term Outcomes in Patients With Acute Decompensated Heart Failure
por: Mo, Ran, et al.
Publicado: (2021)

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
por: Rohm, Ilonka, et al.
Publicado: (2016)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
por: Sattar, Yasar, et al.
Publicado: (2019)

Heart Failure and Mortality of Adult Survivors from Acute Myocarditis Requiring Intensive Care Treatment - A Nationwide Cohort Study
por: Chang, Jung-Jung, et al.
Publicado: (2017)

Ivabradine: A Potential Therapeutic for Children With Refractory SVT
por: Younis, Nour K., et al.
Publicado: (2021)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Development and Validation of a Prediction Model for Acute Kidney Injury Among Patients With Acute Decompensated Heart Failure
por: Wang, Lei, et al.
Publicado: (2021)

Development and Validation of a Prediction Model for Irreversible Worsened Cardiac Function in Patients With Acute Decompensated Heart Failure
por: Wang, Lei, et al.
Publicado: (2021)

Associations between serum electrolyte and short-term outcomes in patients with acute decompensated heart failure
por: Zhao, Kai, et al.
Publicado: (2022)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study
por: Nishimoto, Yuji, et al.
Publicado: (2020)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
por: Urbanek, Irmina, et al.
Publicado: (2014)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Association of ivabradin use with ventricular arrhythmias in heart failure patients
por: Pay, L, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d198u3d720rfambqs9oid9r88l